跳至主要内容
临床试验/NCT06364735
NCT06364735招募中不适用

Entities and Variables Related to Catch-up Growth in Pediatric Patients With Celiac Disease (CD) on a Gluten-free Diet (GFD)

ASST Fatebenefratelli Sacco1 个研究点 分布在 1 个国家目标入组 900 人开始时间: 2024年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
900
试验地点
1
主要终点
Measure the catch-up growth degree.

研究概览

简要总结

A retrospective monocentric observational no-profit study with the aim of evaluating the entity and potential variables influencing the catch-up growth of childhood gluten-free diet patients with celiac disease during a 10-year follow-up. The only extrapolation of the data collected in anonymized form from the medical records of patients who match the necessary study criteria will be planned in order to achieve this aim. A 900-patient sample size will be planned.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • celiac disease diagnosis established at the V. Buzzi Children's Hospital in Milan between January 2010 and December 2020, excluding the extremes, in accordance with the ESPGHAN 2012 or 2020 recommendations.

排除标准

  • patients with unclear or non-specific duodenal histological alterations (e.g., atrophy with unavailable or negative specific antibodies for celiac disease);
  • patients with additional chronic illnesses;
  • absence of the data required for the study;
  • patients with IgA deficiency, defined as IgA <20 mg/dl in children <3 years old or with levels that are below normal for their age.

结局指标

主要结局

Measure the catch-up growth degree.

时间窗: 6 and 24 month

Changes in the auxological weight variable in pediatric patients with celiac disease were measured 6 months and 24 months after they started a gluten-free diet. The change was expressed as an average daily weight increase and compared with the average increase expected for sex and age in a healthy population extrapolated from validated curves (Cacciari).

次要结局

  • Calculate the degree of catch-up growth(6 and 24 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elena Groppali

MD

ASST Fatebenefratelli Sacco

研究点 (1)

Loading locations...

相似试验

进行中(未招募)
1 期
Growth and Development Study of Alglucosidase Alfa.Pompe diseaseMedDRA version: 20.1Level: PTClassification code 10053185Term: Glycogen storage disease type IISystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2021-005552-11-Outside-EU/EEAGenzyme Corporation
已完成
不适用
A prospective, longitudinal study of growth, nutrition and sedentary behaviour in young children with cerebral palsy to measure growth, dietary intake, physical activity, participation, health resource use and quality of lifeMusculoskeletal - Other muscular and skeletal disordersNeurological - Other neurological disordersCerebral Palsy
ACTRN12611000616976niversity of Queensland182
进行中(未招募)
1 期
ong-term monitoring of growth and development of pediatric patients previously treated with everolimusSubependymal Giant Cell Astrocytoma (SEGA) associated with Tuberous Sclerosis Complex (TSC)MedDRA version: 21.0Level: LLTClassification code 10045138Term: Tuberous sclerosisSystem Organ Class: 100000004850
EUCTR2013-003795-13-BEovartis Pharma Services AG48
进行中(未招募)
1 期
ong-term monitoring of growth and development of pediatric patients previously treated with everolimusSubependymal Giant Cell Astrocytoma (SEGA) associated with Tuberous Sclerosis Complex (TSC)MedDRA version: 17.1Level: PTClassification code 10045138Term: Tuberous sclerosisSystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2013-003795-13-PLovartis Pharma Services AG48
招募中
不适用
Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United KingdomChronic Lymphocytic Leukemia, CLL
NCT05557695AstraZeneca287